Innovations in pharmacy最新文献

{"title":"Using 15-Minute Serial Blood Pressures as an Alternative to Measuring a Single Blood Pressure.","authors":"Ann M Philbrick, Caroline S Carlin, Ila M Harris, Christopher Fallert","doi":"10.24926/iip.v14i4.5565","DOIUrl":"10.24926/iip.v14i4.5565","url":null,"abstract":"<p><p>Thirty-minute office blood pressure (OBP-30) is an alternative to ambulatory blood pressure (BP) measurement, yet is impractical to implement. This study aimed to determine whether unattended BP readings over 15 minutes would result in a similar probability of obtaining a BP of <140/90. Sixty-seven adults self-described as having high BP were analyzed. BP was measured at baseline and every 5 minutes for 15 minutes with the initial reading compared to the average of the last three readings (OBP-15). Compared to baseline, there was a decline in both average systolic (4.2 points) and diastolic (2.8 points) BP. The probability of BP control predicted by multivariate model was 71.6% at baseline and 78.0% using OBP-15 (p=0.011). The increase in BP control from initial to OBP-15 measurement was significant for indigenous or persons of color compared to whites, and men compared to women. OBP-15 is convenient and results in lower BP readings and higher probability of BP control compared to the initial reading.</p>","PeriodicalId":501014,"journal":{"name":"Innovations in pharmacy","volume":"14 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10939486/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140145029","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"More Insights Regarding a Global Pharmacy Council.","authors":"Dominique Jordan, Catherine Duggan","doi":"10.24926/iip.v14i2.4803","DOIUrl":"https://doi.org/10.24926/iip.v14i2.4803","url":null,"abstract":"","PeriodicalId":501014,"journal":{"name":"Innovations in pharmacy","volume":"14 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653727/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138465311","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Training and Education Requirements for Pharmacists in Zero Gravity Environments.","authors":"Muhammad Ahmer Raza","doi":"10.24926/iip.v14i2.5540","DOIUrl":"https://doi.org/10.24926/iip.v14i2.5540","url":null,"abstract":"Dear Editor, I am writing to address the critical issue of training and education requirements for pharmacists working in zero gravity environments. With the advancement of space exploration and the potential for long-duration missions , it is crucial to equip pharmacists with the specialized knowledge and skills needed to provide pharmaceutical care in this unique setting. In this letter, I will discuss future potential roles of pharmacist in space, present a table outlining the necessary training areas for pharmacists working in zero gravity environments, address unique challenges, provide recommendations and propose solutions for creating a supportive ecosystem of pharmacy in zero gravity environments.","PeriodicalId":501014,"journal":{"name":"Innovations in pharmacy","volume":"14 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653726/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138465313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Impact of an interdisciplinary patient care model and routine screening on clinical outcomes in patients with hepatitis C.","authors":"Vincent Lam, Christine Dimaculangan","doi":"10.24926/iip.v14i2.5114","DOIUrl":"https://doi.org/10.24926/iip.v14i2.5114","url":null,"abstract":"<p><p>Testing for hepatitis C in hospital emergency departments (ED) and linkage to care to clinics have been reported to provide the most opportunity for screening patients and facilitating continuum of care. Treatment model initiatives have expanded to include telehealth services and open treatment capacity to non-physician providers, such as pharmacists. This study's objective was to assess the impact of implementing automated routine screening for hepatitis C virus (HCV) and a clinical pharmacist into the interdisciplinary care model on HCV diagnosis and treatment outcomes. This retrospective cohort study compared outcomes in a pre-intervention and post-intervention group. Patients were screened and diagnosed with HCV at Jersey City Medical Center (JCMC) and completed linkage to care at JCMC Center for Comprehensive Care. Interventions were the implementation of automated routine HCV screening in the ED and addition of a clinical pharmacist to the interdisciplinary patient care model. Primary endpoints analyzed the number of patients who have achieved sustained virologic response after 12 weeks of treatment (SVR12) and patients who have completed treatment with no reported record of SVR12. Secondary endpoints analyzed the number of patients lost to follow-up, appointment type, time spent in appointments, and clinical pharmacist specialist interventions. Data was collected as categorical variables and chi-squared tests assessed if there were differences between the two samples. Data was collected from 46 patients in the pre-intervention group and 37 patients in the post-intervention group. Patients consisted of mostly males. Ages ranged from 27 to 83 years old. Race included Black, White, Asian, and Other. This study's results showed the positive impact on implementation of routine screening, telehealth services, and an interdisciplinary team approach to HCV diagnosis and management. Given the timeframe, it also showed the potential positive impact on these interventions during a global pandemic.</p>","PeriodicalId":501014,"journal":{"name":"Innovations in pharmacy","volume":"14 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653720/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138465310","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Solutions for Atrial Fibrillation Edvocacy (SAFE): Improving Awareness And Access To Afib Screening For Detection And Referral For Treatment.","authors":"Jonathan Little, Aaron J Bonham, Benjamin M Bluml","doi":"10.24926/iip.v14i2.5477","DOIUrl":"https://doi.org/10.24926/iip.v14i2.5477","url":null,"abstract":"<p><p><b>Background:</b> Atrial Fibrillation (Afib) can lead to stroke and heart failure, and early detection of Afib is an effective method of preventing these life-threatening conditions. An estimated 2.7 million Americans are living with Afib¹, a number that is expected to rise dramatically in the coming years. <b>Methods:</b> The aim of this demonstration project was to create an additional access point in the community at local pharmacies for Afib screening, detection, and referral to physicians for follow-up and initiation of evidence-based therapy when appropriate. This prospective research study was conducted with 14 community pharmacies across the US, in which a total of 650 patients were screened for Afib. Pharmacists conducted SAFEty Risk Assessments that consisted of completion of a Stroke Risk Scorecard and EKG determination utilizing AliveCor's KardiaMobile^® 6L device. <b>Results:</b> In 552 (82.5%) of 669 total EKG readings, a \"normal\" rhythm was detected, and in 117 (17.5%) EKG readings an abnormal detection occurred. A total of 12 out of 650 patients (1.8%) received EKG readings of Afib, which is greater than double the expected prevalence of Afib in the US (0.81%), a statistically significant finding (p < 0.0001). Other notable findings included 42 (6.3%) EKG readings of Wide QRS, and 26 (3.9%) EKG readings of tachycardia. A total of 44 patients were referred to physicians for follow-up on their risk for Afib. <b>Conclusions:</b> Community pharmacies offer a unique, valuable access point for patients to receive Afib screenings. Pharmacists are well positioned to make a significant contribution in the cardiovascular health of their patients and increase the value of team-based health care.</p>","PeriodicalId":501014,"journal":{"name":"Innovations in pharmacy","volume":"14 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653716/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138465312","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Evaluation of a Patient Education Game Design Activity.","authors":"Andrea L Porter, Olivia Kim, Olufunmilola Abraham","doi":"10.24926/iip.v14i2.5019","DOIUrl":"https://doi.org/10.24926/iip.v14i2.5019","url":null,"abstract":"<p><strong>Background: </strong>Game-based learning has been used in pharmacy education settings with the instructor developing a game for students to play to enhance learning. However, there is a paucity of data about health sciences students designing a game themselves to further their understanding of a complex topic. The purpose of this study was to describe and assess a game design activity focused on patient education of anticoagulants in a pharmacotherapy skills laboratory setting.</p><p><strong>Innovation: </strong>Second-year pharmacy students enrolled in a pharmacotherapy skills laboratory course worked in teams in a one-hour active learning activity to design a game intended to educate patients about their medication. A pre/post analysis of student attitudes about game-based learning and the activity, as well as knowledge, was conducted.</p><p><strong>Findings: </strong>The large majority of students (80.5%) agreed that the activity was an effective way to develop patient education strategies. Through the survey and free-response questions, students reported that the game design activity facilitated positive group collaboration and allowed students to take the perspective of their patients. Students also requested additional time to complete the activity. Knowledge assessment scores of key patient education points increased from 66.5% prior to the activity to 71.5% one week following the activity (p<0.05).</p><p><strong>Conclusion: </strong>The game design activity served as a novel teaching method for pharmacy students to actively learn about anticoagulant medications while developing an innovative patient education strategy. Although there was an increase in knowledge scores, students highlighted the impact on group collaboration and taking the perspective of their patients.</p>","PeriodicalId":501014,"journal":{"name":"Innovations in pharmacy","volume":"14 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653723/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138465309","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}